Vivien Azer

Tilray Canada, a subsidiary of medical cannabis company Tilray Inc (NASDAQ: TLRY), entered into a global collaboration agreement with Sandoz AG, a generic pharmaceuticals and biosimilars company that's part of Novartis AG (NYSE: NVS). The agreement marks an expansion of an existing relationship...

Cowen analysts recently published an in-depth valuation of key players in the cannabis industry drawing from historical data and market trend. The valuation includes an outline of the potential market opportunity for the cannabis sector beyond legalization in Canada next week. Cowen's...

Cowen has revisited its models for cannabis companies Tilray Inc. (NASDAQ: TLRY) and Canopy Growth Corp. (NYSE: CGC) amid volatility in the emerging market. The Analyst Vivien Azer maintained an Outperform rating on both Canopy Growth and Tilray. The analyst raised the price target...

Cowen is taking a more constructive view on Canopy Growth Corp. (NYSE: CGC)'s early lead in the cannabis industry after a meeting with the marijuana company's management. The Analyst Cowen analyst Vivien Azer maintained an Outperform rating on Canopy Growth's Canadian stock ...

Philip Morris International Inc. (NYSE: PM) reported second-quarter results Thursday that prompted Cowen drop its bullish stance on the cigarette maker.  The Analyst Cowen's Vivien Azer downgraded Philip Morris from Outperform to Market Perform with a price target lowered...

This was a huge week for the marijuana industry: Canada became the second country in the world to legalize cannabis for recreational uses. “October 17 was set as the first day for recreational sales. Some people in the industry wanted an earlier date, but at least companies can now make plans...

After striking a 10-year high in June, Altria Group Inc (NYSE: MO) saw a 16-percent pullback driven largely by the Food and Drug Administration’s call to reduce cigarette nicotine. Cowen Equity Research had initially reacted to the news with a $60 price target and Hold rating, but now, amid...

Boston Beer Company Inc (NYSE: SAM), an early pioneer and current leader in the craft beer space, has been hit hard by the rise in popularity and increasing competition of the multitude of craft brewery’s over the past few years. With shares down nearly 20 percent year to date, fundamental...

America’s self-medication preferences may be making a major long-term shift. In celebration of 4/20, Cowen analyst Vivien Azer took a look at what could be a coming cyclical upswing for marijuana and a cyclical downswing for alcohol. According to Azer, what’s good for the marijuana...

Cowen and Company reiterated its Outperform rating on Reynolds American, Inc. (NYSE: RAI), saying that the company's better positioning with ASU30 (adult smokers under 30) consumers would propel structurally faster growth in the future. Reynolds American shares are down 6.2 percent since their pre-...